Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

New PTO guidelines to affect biotech inventions; they address requirements for utility and written description, stress patentability of DNA

Article Abstract:

The application of the patent guidelines' utility and written description requirements to biotechnology patents is discussed. Those issued in Jan 2001 focus on the patentability of genomic material, arguing for patents of isolated and purified DNA since it differs from the naturally occurring form.

Author: Weiswasser, Elizabeth Stotland
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Policy issues could have major impact on industry; privacy, discrimination, IP, research restrictions and reimbursement top the list

Article Abstract:

The effect on the biotechnology industry of pending laws on genetic privacy and discrimination, as well as those on research and intellectual property in the area are discussed. Congress has failed to enact genetic privacy legislation despite wide public concern.

Author: Bentivoglio, John T., Cochran, Martha L.
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 2001
Laws, regulations and rules, Protection and preservation, Privacy, Right of, Right of privacy, Genetic discrimination

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Biotechnology industry, Biotechnology industries, Intellectual property
Similar abstracts:
  • Abstracts: Medical savings accounts. Effective retirement planning seminars: painting by the DOL numbers. Managed care and quality
  • Abstracts: Memorandum regarding the adoption of amendments to regulation S under the Securities Act of 1993. Memorandum from Cravath, Swaine & Moore regarding sales of convertible securities of U.S. reporting companies under regulation S (August 24, 1998); re: sales of convertible securities of U.S. reporting companies under regulation S
  • Abstracts: Market volatility will affect merger negotiations. Insurance is available for pharmaceutical recalls; CGL and all-risk policies should together cover third-party liabilities and first-party costs
  • Abstracts: The impact of investment volatility on wealth transfer strategies. When is a private foundation an appropriate strategy?
  • Abstracts: Giving up their kids; mentally ill children, and the custody crisis you never heard of. Two dads, two responses; lawyers stand on opposite sides in adoption rights fight
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.